LIBERTYVILLE, Ill., July 01, 2024 (GLOBE NEWSWIRE) — A-S Medication Solutions (ASM) today announced a strategic transition of its relationship with Triple Aim Consulting, LLC (“TAC”).
For a number of years, ASM has had a consulting agreement with TAC for TAC to assist ASM in managing client accounts. That consulting agreement ended on June 28, 2024.
“ASM is committed to increasing access to medications all across the United States,” said ASM CEO Matt Hoff. “We are proud of our tireless dedication to serving patients in all 50 states.”
Matt Hoff
Chief Executive Officer
(678) 488-7524
https://www.a-smeds.com/testimonials
GlobeNewswire,is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Latest posts by GlobeNewswire (see all)
- LNW Investor News: If You Have Suffered Losses in Light & Wonder, Inc. (NASDAQ: LNW), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - April 26, 2025
- 798 Art District and Beijing International Film Festival Jointly Launch “Art Lights the Screen” – A Cultural Feast of Film and Art - April 26, 2025
- RAD-140 SARMs – Rad 140 Testolone Benefits, Dosage, Safety, and Where to Buy Sarms Online (by Crazy Bulk USA) - April 26, 2025
